Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

Sex Toys Improve Your Sex Life & Ella Paradis Has the Proof

Leave a comment


News Image

Sex toys and specifically vibrators have become increasingly popular with the stigma of sex and sex toys being lifted in the recent years. The data from Ella Paradis’ survey serves as proof society is open to the thought of sex toys and embracing their possible benefits.


MIAMI (PRWEB)

A study conducted by Ella Paradis, leading online retailer of sexual health & wellness products, revealed 86.2% of people believe sex toys improve their sex life, and 83.1% of people intend to use sex toys this Valentine’s Day. 1,160 of users participated in this study asking questions about why people are using toys and what type of toys they are using.

“When I started Ella Paradis, my goal was to improve the sex lives of those around me. I heard stories of women with certain health conditions making it extraordinarily difficult to reach orgasm. I’ve met men with performance issues due to diabetes. The trans community has told me sex toys make it possible to connect with their partner,” remarked Tino Dietrich, CEO of Ella Paradis. “But to see the data proving sex toys have improved sex lives, I know my mission has only just begun.”

Since so many respondents feel sex toys improved their sex lives, Ella Paradis took this one step deeper to better understand the why behind this feeling. With 86.2% of their respondents noting they use a vibrator, they asked the question, “Why do you use a vibrator?”

32.6% of respondents noted “There’s no specific reason, just because,” showing how most people have no specific reason, but the fact that they do significantly improves their sex life. 29% of respondents noted it allows them to experience a blended orgasm during sex, which is a combination of both a vaginal and a clitoral orgasm. 15.9% noted they have a better orgasm from a vibrator than from sex, 11.6% said they struggle to reach orgasm with their partner during sex, and 8.37% noted they use a vibrator because they don’t have a partner. That means 56.5% of respondents use a vibrator to amplify their sexual experience in some way, shape or form.

With the majority using a vibrator during sex, the next question inquired the frequency of which respondents use a vibrator during sex. 72.5% noted sometimes, 17.4% every time, and only 10.1% noted never. This means, a whopping 89.9% of respondents use a vibrator during intercourse, whether sometimes or all the time. Given this information, Ella Paradis went even deeper to see what type of vibrators are being used during sex.

54.3% said a clitoral stimulator, which encompass multiple types of vibrators as it’s anything stimulating the clitoris. This could be a wand, a bullet, a finger vibrator, or a suction/sonic wave vibrator engulfing the clitoris without touching it to prevent hyper-stimulation. 14.5% said other, 13% said a traditional/rabbit vibrator, 6.5% said wand, 5.8% said a bullet/finger vibrator and 5.1% said a dildo. This falls in line with current statistics stating around 70% of women require clitoral stimulation to reach orgasm.

As mentioned in the beginning of this article, 83.1% of respondents noted they intend to use sex toys this Valentine’s Day while 16.9% said they did not intend to use toys this upcoming holiday. With this in mind, Ella Paradis further inquired as to what type of sex toy they will be using this Valentine’s Day.

Falling in line with the popularity of vibrators and vibrator sex, the majority (39.8%) noted they will be using a vibrator, 36.1% said they will be using multiple sex toys, 6.8% said a cock ring, 4.5% said bondage toys, 4.5% said a dildo, 4.5% said other and only 3% noted they will be using anal toys.

Sex toys and specifically vibrators have become increasingly popular with the stigma of sex and sex toys being lifted in the recent years. The data from Ella Paradis’ survey serves as proof society is open to the thought of sex toys and embracing their possible benefits. To learn more about these toys and to find something for yourself or your partner this Valentine’s Day, head to the Ella Paradis website!

Company Information

Founded in 2015, Ella Paradis is on a mission to bring everyone pleasure with premium products and quality service. They hope to empower adults by providing optimal solutions, resources and content to improve their quality of life through informed decisions on sexual health and wellness. They are working to provide an environment where everyone feels comfortable embracing their sexuality without feeling shamed or degraded. They are committed to making the experience of pleasure affordable and accessible for everyone, while simultaneously breaking stigmas surrounding sexuality.

Share article on social media or email:

Health

TurningPoint Global Solutions Wins Contract to Manage NIH’s Mobile Devices and Services

Leave a comment


TurningPoint

“Mobile devices are increasingly important tools that NIH researchers, clinicians, and staff will use as they work in a variety of settings to enhance health, lengthen life, and reduce illness and disability.”


ROCKVILLE, Md. (PRWEB)

TurningPoint Global Solutions today announced that the National Institutes of Health has awarded it and subcontractors ISEC7 and IncrediTek a five-year contract to manage mobile devices and services across the NIH enterprise. The contract will consolidate the procurement, management, and distribution of all mobile devices and wireless telecommunications services and allow TurningPoint to serve NIH in recommending solutions that will reduce costs while improving quality. TurningPoint’s services will be enabled through its Network Inventory and Optimization Solution (NiOS®) telecom business management web-based portal.

Managing Partner David Hughes said TurningPoint will provide NIH with a tailored service offering and function as a trusted partner in helping NIH leverage technology to enable its mission objectives.

“We recognize the importance of this contract as NIH’s expectations for mobile telecommunications technologies and services will continue to grow,” said Hughes. “Mobile devices are increasingly important tools that NIH researchers, clinicians, and staff will use as they work in a variety of settings to enhance health, lengthen life, and reduce illness and disability.”

This latest win will expand TurningPoint’s footprint at NIH to all 27 of its Institutes and Centers. The award is 100 percent federally funded with a total contract value of $99,919,798.48 if all options are exercised.

ABOUT TURNING POINT GLOBAL SOLUTIONS

Headquartered in Rockville, MD, TurningPoint provides telecom lifecycle and expense management software and services for wireless and wireline services, with a focus on federal and other public sector organizations. The GSA Managed Mobility Program has recognized TurningPoint as a preferred supplier for Mobile Lifecycle & Expense Management services since 2014. TurningPoint also provides software engineering and professional IT services for a diversified group of commercial and government customers. TurningPoint is appraised at CMMI Maturity Level 4 for Development and CMMI Maturity Level 3 for Services. TurningPoint is also IS0 27001:2013 certified for its data center hosting services. For more information, visit http://www.tpgsi.com.

Share article on social media or email:

Health

Skincare Industry Veteran Scott Friedman Named Vice President of Professional Skincare Division for F.C. Sturtevant, Manufacturer of Columbia Probiotic Products

Leave a comment


News Image


BRONXVILLE, N.Y. (PRWEB)

The F.C. Sturtevant Company, America’s first skin care company, announced that skincare industry veteran Scott Friedman has been named Vice President of the Professional Skincare Division. Friedman will be leveraging his 20 plus years of industry experience to support F.C. Sturtevant’s revolutionary probiotic skincare line, Columbia SkinCare, in the dermatologic and medical spa markets. Columbia SkinCare has received national recognition as the first probiotic product line developed for topical use. The Professional Products Division develops products designed to help balance the body’s microbiome.

“I am very excited to be leading the Columbia Skincare Division of The F.C. Sturtevant Company. The emphasis on quality product development and commitment to comprehensive brand support and product training is best in class,” says Friedman. “Columbia Probiotics technology is the world’s first strain-specific probiotics created for topical usage. These clinically-proven, multi-functional products for all skin types fill a need that currently does not exist in the professional skincare market.”

Friedman’s dynamic and diverse experience includes consulting with Coola Suncare and Fillerina USA and launching both in the physician and medical spa markets, building a successful startup suncare company, MDSolarSciences into a seven-figure sales company, and helping make MedSkin Solutions into a considerable contender in the Americas market. “Scott Friedman is highly respected among colleagues, and he excels in product development,” says company CEO Steven Rosenfeld. Friedman is currently developing the company’s marketing plans for its expanded outreach into the professional skincare markets.

“Having the opportunity to bring in such an experienced leader allows us to maintain our position as a global leader in product development while introducing unique and innovative skincare products,” says Dr. James Ryan, the Company’s Chief Technology Officer. “With an emphasis on the introduction of new technologies and ingredients, we look to continue to expand our position in the dermatology and medical spa marketplace. With Scott’s guidance, we will be introducing several new products over the next 12-18 months.

About The F.C. Sturtevant Company

As America’s first skincare company, F.C. Sturtevant has been manufacturing the Columbia brand since 1871. Our unique products, formulated with natural ingredients, are clinically proven to improve skin’s health and appearance. Columbia Skincare was born out of Francis Crayton Sturtevant’s life work to create medicines to treat infection and belief that fighting infection while preserving “good” bacteria is necessary to balance the body’s ecosystem.

About Columbia Probiotics

Columbia Probiotic skincare products are the first strain-specific probiotic skincare company developed exclusively for topical use. The technology is proprietary and the formulation includes probiotics (“good bacteria”), plant stem cell extracts and amino acids, clinically-proven to help balance the microbiome and enhance the skin’s natural ability to renew itself. Cell regeneration is one of the most important biological factors in minimizing the effects of aging on skin. Our probiotic ingredients work harmoniously with the body’s endocrine, lymphatic, circulatory, integumentary, and immune systems, contributing to overall skin health. Columbia Probiotic products are available through skincare professionals and medical spas as well as online at http://www.columbiaprobiotics.com.

EDITOR’S NOTE: For more information about Columbia Skincare and to arrange to speak with a company spokesperson, please contact Nancy Trent or Pamela Wadler at 212-966-0024 or pam@trentandcompany.com.

Share article on social media or email:

Industry: Healthcare

Olaris Announces Grant from The Michael J. Fox Foundation for Parkinson’s Research

Leave a comment



WALTHAM, Mass. (PRWEB)

Olaris, a precision medicine company that is fundamentally changing how diseases are diagnosed and treated, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). With this funding Olaris will work to identify biomarkers that can detect Parkinson’s disease (PD) at its earliest onset, a critical step to improving PD patient outcomes.

PD affects more than 6 million people worldwide. Currently, there is no single test to diagnose the disease, and it is believed that clinical symptoms do not become apparent until 5-10 years after the disease initially begins, during which time it is estimated that 80% of a patient’s dopaminergic neurons are lost.

“Several proposed PD biomarkers have failed to correlate with the diagnosis or progression of the disease,” said Dr. Elizabeth O’Day, founder and CEO of Olaris. “With this support from The Michael J. Fox Foundation, we will apply our proprietary metabolite profiling platform and customized machine learning algorithms in an effort to identify biomarkers that can accurately detect PD at its earliest onset.”

Olaris’ platform for measuring the metabolome is unique in its use of nuclear magnetic resonance (NMR) spectroscopy to analyze biofluid samples. Olaris has developed custom non-uniform sampling (NUS) techniques that dramatically increase the sensitivity and resolution, while also reducing the time required to collect the data. The company will use its advanced NMR methods and machine learning algorithms to uncover the metabolic fingerprint of Parkinson’s patients with a LRRK2 gene mutation, one of the strongest genetic links to the disease. This approach may identify novel metabolic biomarkers or may provide new insight into the underlying role of LRRK2 in Parkinson’s disease.

“Objective markers of Parkinson’s onset and progression would be game-changing for clinical care and research. Our Foundation supports work toward critical biomarker tools, and we are proud to support Olaris in this effort,” said Bradford Casey, PhD, MJFF Associate Director of Research Programs.

To stay up to date with the latest research and news from The Michael J. Fox Foundation, visit http://www.michaeljfox.org/. To learn more about Olaris, visit http://www.olarisbor.com.

About Olaris

Olaris is fundamentally changing how diseases are diagnosed and treated. The company’s metabolomics platform and machine learning algorithms produce “Biomarkers of Response” (BoR), which removes the guesswork when treating an individual patient’s disease. To learn more, visit http://www.olarisbor.com.

Share article on social media or email:

Health: Mental Health

FlexJobs’ Survey Finds Flexible Work Options Positively Impact Mental Health and May Keep People in the Workforce in Tough Times

Leave a comment


“Allowing employees to work flexibly reduces the conflict that we all experience between our personal and professional lives, and equips everyone to better meet their mental, emotional, and physical needs,” said Sara Sutton, Founder, and CEO of FlexJobs.


BOULDER, Colo. (PRWEB)

According to the results of FlexJobs’ Work-Life-Relationship survey, 84% of the 2,100 respondents who have mental illnesses, such as anxiety or depression, said they thought that having a flexible job would help them better manage their mental illnesses. In addition, 35% of the overall pool of 3,900 respondents said they have had to take a break from work because of difficult personal circumstances (i.e., death, divorce, serious physical or mental illness of themselves or a loved one, etc.). Of those, 88% said that if their job had offered flexibility during those circumstances, they would have been able to remain in the workforce.

“As our survey findings confirm, flexible work can play a very positive role in supporting employees who have mental health issues or who are going through difficult life circumstances,” said Sara Sutton, Founder, and CEO of FlexJobs. “According to Mental Health America, more than half of employees are afraid to take a day off to attend to their mental health. Allowing employees to work flexibly reduces the conflict that we all experience between our personal and professional lives, and equips everyone to better meet their mental, emotional, and physical needs. I believe flexible work can help improve the health and happiness of our nation’s workforce and our communities, which is one of the reasons I am such a passionate advocate for it,” Sutton concluded.

83% said that work has conflicted with their efforts to take care of their overall health. However, the results of FlexJobs’ survey suggest that flexible work arrangements can have a positive impact not only on managing mental health, but also improving work-life balance, physical health, romantic relationships, and overall well-being. More findings on these topics below.

Flexible jobs and work-life balance:

Work-life balance tops the reasons people seek flexible jobs (67%). Management heavily influences how workers achieve work-life balance, varying significantly between those who currently have flexible work options and those who do not.

  • • 54% of respondents with flexible work options said their work-life balance was either great or very good, compared to only 29% of respondents without flexible work options who reported the same thing

  • • 21% of respondents with flexible work options say they’re currently stressed by their level of work-life balance, while more than double that, 43%, working without flexible options said the same thing

  • • 35% with flexible work options said “My boss’s work habits make work-life balance easy for me” compared to only 14% of those without flexible work options who said the same thing

  • • 27% with flexible work options said “My boss’s habits make work-life balance difficult for me” but 40% of those without flexible work options said their boss’ habits make work-life balance difficult for them

Flexible jobs and personal health:

  • • 95% of respondents reported that a flexible job would likely make them a happier person in general

  • • 89% thought it would help them take better care of themselves

  • • 86% believed it would decrease their levels of stress

  • • 67% thought it would increase the frequency they exercised

Flexible jobs and non-romantic relationships:

  • • 88% of respondents said having a flexible job would create more time to spend with family

  • • 78% thought it would help them be more available for friendships in their life

  • • 94% of those with children (or plan to have children someday) thought a job with work flexibility would help them be a better parent

  • • 85% of those with pets said it would help them be a better pet owner

Flexible jobs and romantic relationships:

  • • 64% of respondents said having a flexible job would likely benefit their romantic relationship overall

  • • 64% said it would likely improve their sex life

  • • 80% thought that having a job with work flexibility would help them be a more attentive spouse/partner/significant other

  • • 53% thought it would increase time available for dates/date nights

Among other findings, 100% remote work remains the most popular choice for flexible work (80%) for the fifth year in a row, with flexible schedules a second preference (55%), followed by remote work some of the time (4%), part-time schedules (34%), and freelance work (32%).

Companies in the U.S. have added the most workers since May 2015, making it a robust market for job seekers. For people interested in finding remote jobs, FlexJobs recently announced the Top 100 Companies for Remote Jobs in 2020.

To learn more, visit: https://www.flexjobs.com/blog/post/survey-flexible-work-mental-health/ or please contact Kathy Gardner at kgardner@flexjobs.com.

About FlexJobs

FlexJobs is a premium online job service for professionals seeking flexible work, specializing in full-time and part-time remote jobs, employee and freelance jobs, and on-site jobs with flexible, part-time, and alternative schedules. Since its start in 2007, FlexJobs has helped more than 4 million people in their job searches and has created the largest vetted database of legitimate flexible job opportunities in over 50 career categories. In addition, FlexJobs provides robust career support, including curated expert resources and career coaching services, to partner with job seekers in all phases of their journey. A trusted source in the media, FlexJobs has been cited in top national outlets such as CNN, Wall Street Journal, New York Times, CNBC, Forbes, and many others. FlexJobs’ Founder & CEO Sara Sutton has also launched two additional partner sites, Remote.co and 1 Million for Work Flexibility, to help provide education and awareness about the viability and benefits of flexible work. Sutton is the creator of The TRaD* Works Forum (*Telecommuting, Remote, & Distributed), dedicated to helping companies leverage the benefits of telecommuting, remote and distributed teams.

Share article on social media or email:

Health

ABA Business Growth Successfully Addresses the Problem of Talent Acquisition and Retention in the Applied Behavior Analysis Field.

Leave a comment


https://aba-businessgrowth.com

Are you struggling to find the best ways to communicate with BCBA® and RBT® professionals? ABA Business Growth supports and fosters a 20,000+ BCBA® and RBT® community of professionals actively looking for career opportunities. This includes the only RBT® candidate database in the market!


PALO ALTO, Calif. (PRWEB)

ABA Business Growth is a world-wide leader in talent recruitment and retention services for ABA organizations.

Applied Behavior Analysis (ABA) is an evidenced-based intervention that, with early and intensive application of quality programming, has demonstrated a 47% success rate helping children with autism to mainstream. The world, however, is experiencing an acute shortage of certified ABA experts, Board Certified Behavioral Analysts (BCBAs), and Registered Behavior Technicians (RBTs) to support the world’s autism population. ABA Business Growth is committed to helping organizations solve this growing talent crisis.

The organization uses a powerful multi-level approach to recruiting to find skilled candidates that match the unique needs and business culture of ABA businesses. They go beyond basic technical and clinical skill requirements and take into account many different factors and dimensions to provide your organization and potential candidates with a thoughtful match.

Learn how ABA Business Growth may help you build and grow your team at https://aba-businessgrowth.com.

Their recruiting services include the following key components:

ELITE RECRUITING AND TALENT MANAGEMENT

ABA Business Growth’s recruiting and talent management services focus on helping organizations find the very best BCBA® and RBT® candidates. Finding even one BCBA® and RBT® for an open position in today’s marketplace is difficult, and with the field growing at an exponential rate, the need for multiple clinicians and technicians continues to increase.

ABA Business Growth utilizes an innovative Pipeline Development Recruiting Model, which provides a select list of qualified candidates. They do the work for you so that your organization may stay focused on providing the highest quality care possible.

ACCESS CANDIDATES THROUGH THEIR PROPRIETARY BCBA AND RBT DATABASE

Are you struggling to find the best ways to communicate with BCBA® and RBT® professionals? ABA Business Growth supports and fosters a 20,000+ BCBA® and RBT® community of professionals actively looking for career opportunities. This includes the only RBT® candidate database in the market!

ABA Business Growth gives organizations the opportunity to deliver an impactful and targeted email marketing campaign to their candidate community. This allows you to connect with qualified candidates who want to hear from you! Our open rates for email marketing campaigns are an impressive 25-40%!

For more information about all our ABA Business Growth services, visit their website at https://aba-businessgrowth.com.

Share article on social media or email:

Health

A Personal Choice Tubal Reversal Center Sponsoring the First Ever Free Tubal Reversal Surgery Contest

Leave a comment



RALEIGH, N.C. (PRWEB)

As of January 1st 2020, A Personal Choice Tubal Reversal Center is offering free tubal reversal surgery by sponsoring the first ever Free Tubal Reversal Surgery Contest. This opportunity to have free tubal ligation reversal surgery is the first of its kind.

Dr. Charles Monteith is a sterilization reversal surgeon who is responsible for sponsoring the contest. He is the Medical Director of A Personal Choice Tubal Reversal Center, which is a specialty surgical center located in Raleigh, North Carolina. The center exclusively offers patients affordable, outpatient sterilization reversal for both women and men. Those who enter the Free Tubal Reversal Surgery Contest will have a chance to win a sterilization reversal surgery valued at up to $8,000. Each year, Dr. Monteith will select up to four (4) lucky winners who will be eligible to win either tubal ligation reversal surgery or vasectomy reversal surgery at no cost to them. This is the first time free sterilization reversal surgery has been offered in the United States.

Tubal ligation and vasectomy are very popular forms of permanent birth control. Each year approximately 700,000 tubal ligation surgeries (female sterilizations) and up to 500,000 vasectomy surgeries (male sterilization) are performed each year in the United States. Medical research has demonstrated up to 30% of women who have tubal ligation and 10% of men who have vasectomy will regret their sterilization procedures and desire to have more children. Their options for having another child are limited to adoption, in-vitro fertilization (IVF), and sterilization reversal. All of these options are expensive and none of them are guaranteed.

Adoption can cost up to $50,000 and up to 15% of adoptions will not be successful. A single cycle of IVF can cost up to $15,000 and a single IVF treatment cycle is approximately 30% successful. Sterilization reversal surgery is not guarantee but can be more successful than IVF. Sterilization reversal surgery can be up to 95% successful for men and up to 80% successful for women. Costs of sterilization reversal surgery range from $7,000 to $30,000 depending on where the surgeries are performed. Unfortunately, most health insurance plans consider surgeries to reverse self-imposed sterilization as non-essential, elective medical treatments and most plans will not cover the cost of either reversal surgery or IVF. This leaves many couples having to pay out of pocket for the treatment of their regret.

Many couples will quickly realize sterilization reversal surgery can be the most affordable option providing the best chance of pregnancy success. Despite sterilization reversal being more affordable, many who choose sterilization reversal will have to spend their life’s savings, borrow from their retirement plans, or endure high surgery financing interest rates in an effort to afford reversal surgery. Dr. Monteith continually receives requests from couples in despair because they can not afford the high cost of reversal surgery. These couples asking if he would consider performing free or probono reversal surgery on their behalf. Many will tell him they are not able to afford the surgery and inquire if there are research trials offering free infertility treatment. After years of continually receiving these request, Dr. Monteith decided he could help a few of these couples each year by sponsoring a reversal surgery contest.

Applications are already rolling in! Within the first two weeks, Dr. Monteith has already received over 800 contest entries. Some of the statements made by those entering the contest are truly heartbreaking and revealing of the many different reasons people regret their sterilization surgery.

One contestant wrote on her application, “Thank you so much for offering this contest. I lost my children in a house fire and have been emotionally devastated. I looked into IVF and was not able to afford IVF. My local fertility doctor quoted me over $20,000 for reversal surgery. Your contest is giving me hope that I can one day be a mom again.”

Another contestant wrote, “I was in an abusive relationship and the victim of domestic violence. I had my tubes tied so I would not be further trapped with my abuser by having more children with him. I have since divorced and now I am with a man who is the love of my life. He supports me, is not abusive to me, and is a real father to my children from my previous relationship. Tubal reversal surgery would allow me the chance to give him a child.”

Another entry read, “I was advised to have a tubal ligation after being diagnosed with a potentially deadly heart condition. I have never had children. My health has dramatically improved over the last 10 years. I have spent over $30,000 on three IVF treatments and have not become pregnant. Although tubal reversal may not work…at least it will give me hope and a chance…”

Although it can be easy to blame those who chose sterilization and easy to have a “that is what you get” attitude, one can easily see by reading the above comments submitted by contestants that the decision to have sterilization and the decision to reverse sterilization are influenced by many different life circumstances. Dr. Monteith has extensive experience in the field of reproduction and understands the complexity of his patient’s lives. This is why he chose to offer the first contest giving away free tubal reversal surgery and offering couples hope and a chance of becoming new parents again.

For more information and/or to enter this contest, please visit https://www.tubal-reversal.net/free-tubal-reversal-surgery-contest-applications/

For more information about A Personal Choice Tubal Reversal Center, call (919) 977-5050 or visit https://www.tubal-reversal.net:

CONTACT INFORMATION:

A Personal Choice Tubal Reversal

Dr. Charles W. Monteith, Jr., M.D.

(919) 977-5050

ContactUs@tubal-reversal.net

3613 Haworth Drive, Raleigh NC 27609

Share article on social media or email:

Health

FDAnews Announces — Early Bird Pricing Ends on Feb. 18 for FDA Data Integrity: For Device and Pharma Firms, and Their Suppliers Workshop March 17-18, 2020

Leave a comment


WCG FDANews

WCG FDANews


FALLS CHURCH, Va. (PRWEB)

FDA Data Integrity

For Device and Pharma Firms, and Their Suppliers

An interactive workshop presented by Cerulean Associates LLC and FDAnews

March 17-18, 2020

Doubletree Hotel Philadelphia Center City • Philadelphia, PA https://www.fdanews.com/fdadataintegrity

Early bird pricing for the FDA Data Integrity: For Device and Pharma Firms, and Their Suppliers Workshop ends on Feb.18.

FDA gives simple instructions to its investigators: “If initial findings indicate the firm’s electronic records may not be trustworthy and reliable, or when electronic recordkeeping systems inhibit meaningful FDA inspection, a more detailed evaluation may be warranted.”

That’s the polite way of saying this is when one can expect to receive a Form 483 or warning letter.

With increased scrutiny on data integrity, establishing internal competency and assessment programs is essential.

Join award-winning FDA compliance expert, author and Cerulean founder John Avellanet for the interactive workshop: Data Integrity for Device and Pharma Firms, and Their Suppliers. He is recognized globally for his business-savvy pragmatic advice and engaging speaking style.

During the 10 workshop sessions, attendees will:

  • Identify likely risks and select the most appropriate controls

  • Work to review audit trials and case study situations to determine the data integrity failures

  • Review case study validation tests to see if data integrity is actually being verified

  • See hundreds of questions and audit points to consider for internal and supplier audits

  • Understand what departments need to be involved – who should take a leading role, how, and why

  • Draft a personal business case and plan for implementing a data integrity control framework at ones company


After two days of ‘total immersion’ study, one will return to the office with increased understanding based on team exercises and case studies… informative, detailed explanations… and honest no-holds-barred discussions with John and fellow attendees.

Early bird pricing ends on Tuesday, Feb. 18.

Conference Details:

FDA Data Integrity

For Device and Pharma Firms, and Their Suppliers

An interactive workshop presented by Cerulean Associates LLC and FDAnews

March 17-18, 2020

Doubletree Hotel Philadelphia Center City • Philadelphia, PA https://www.fdanews.com/fdadataintegrity

Tuition:

Early Bird Pricing: $1,597 (available until Feb. 18, 2020)

Regular Pricing: $1,797 (after Feb. 18, 2020)

Significant team discounts are available.

Easy Ways to Register:

Online: https://www.fdanews.com/fdadataintegrity

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative,

and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations.

Share article on social media or email:

Health

R3 Medical Training is Now Registering for PDO Thread Lift Training Certification Course March 11-12, 2020 in Las Vegas

Leave a comment


thread lift training course

The Best PDO Thread Lift Certification Course March 11-12, 2020 Call (888) 988-6343

Not only do attendees learn how to make thread lift placement decisions, but also get to perform them on real patients! The immersive experience really hits home with the new skill set, and providers will be able to immediately implement threads in practice!


LAS VEGAS (PRWEB)

R3 Medical Training is now enrolling for its PDO Thread Lift Training Course scheduled for March 11-12th, 2020 in Las Vegas. The training consists of thread lift placement on real patients for the face, abdomen and other areas as well. Call (888) 988-6343 to register.

PDO thread lifts represent an excellent alternative currently for nonoperative facelift. The procedures are safe, quick and with the latest thread lift technology very effective. R3 Medical Training utilizes threads from PDO Max, which are FDA cleared with over 10 different styles.

For the thread lift certification training, attendees will learn who is a good candidate, how to decide placement and then perform the procedures with expert certified trainers.

According to R3 Medical Training CEO David Greene, MD, MBA, “It’s hard to learn thread lift techniques from videos, as there are quite a few nuances. Not only do attendees learn how to make decisions, but also get to perform them on real patients! The immersive experience really hits home with the new skill set, and providers will be able to immediately implement threads in practice!”

Attendees routinely rave about R3 Medical Training’s setup, as there are no cadavers or models. Only real patients are brought in, and it’s been memorable for attendees.

In addition to the live procedures, attendees also receive amazing show specials for thread packages. The savings pay for the course, as attendees also receive a free procedure too.

Added Dr. Greene, “There is no better thread lift training experience. In addition to performing threads on real patients, attendees also can have a procedure in addition to working with regenerative biologics too. Don’t settle on an inferior course that just talks about threads and doesn’t allow for hands on. It’s critical!”

Currently, the PDO Thread Lift Certification Course is included as part of the R3 Regenerative Aesthetics Course. This means that attendees not only get certified in PDO Thread Lifts, but also learn regenerative aesthetic techniques for hair restoration, facial rejuvenation and also sexual health. The stem cell hair restoration training course is an amazing addition to one’s practice, as it works great and saves cost compared to a hair transplant.

To find out more about the PDO Thread Lift training course and the regenerative aesthetics, visit the website http://r3medicaltraining.com/ and call (888) 988-6343.

Share article on social media or email:

Health

Gifford Bioscience Launch New SPR (Biacore) Assay Service

Leave a comment


Macer Gifford, Managing Director added ‘’Biacore is a natural fit within the core competence of Gifford Bioscience: determining how a potential drug binds to its target. Kevin had considerable experience with the technique and we are delighted to have him lead the business stream.”


BIRMINGHAM, England (PRWEB)

In January 2020, Birmingham based preclinical contract research organisation, Gifford Bioscience Limited, launched their new SPR Biacore Assay Service. This is a highly specialised technique, adding further depth to the company’s core competence in receptor pharmacology.

Who Is Gifford Bioscience?

Gifford Bioscience are based on the University of Birmingham’s Research Park, in the United Kingdom. They specialise in providing receptor pharmacology and occupancy studies to biotech companies, large pharma and university researchers.

Gifford Bioscience have quickly built a loyal international client base. Two-thirds of their contracts are repeat business from the scientists they have previously worked with. Half of their business comes from researchers in the United States and a further third from Continental Europe.

Gifford Bioscience is a family firm, founded by two brothers. Dr Andrew Gifford, Chief Scientific Officer, was previously Senior Scientist at Brookhaven National Laboratory in New York. Macer Gifford, Managing Director, was previously deputy CEO of a banking group. Dr Kevin Thompson joined last year, to develop the new business line, bringing with him 25-years’ experience in Biotech Pharma and specialist expertise in SPR (Biacore) Assays.

What are SPR (Biacore) Assays?

Gifford Bioscience’s new SPR (Biacore) Assay service involves immobilising a target receptor onto a biosensor surface in a Biacore T200 instrument. Test compounds are flowed over the biosensor surface to measure their binding and release from the receptor. This methodology is vital for optimising the affinity and receptor residency of candidate drug compounds.

The new service can be divided into two main parts:


  • Kinetic Affinity – Measuring the binding association rate of a compound with its target receptor and then its subsequent dissociation rate to calculate affinity. This technique also measures how long a compound remains bound to its receptor (residency).

  • Equilibrium Binding – For compounds with association and dissociation rates that are too fast to measure using the T200, receptor affinity can be determined from the equilibrium binding response at increasing compound concentrations.

By offering this new service, Gifford Bioscience hope to assist customers to advance their candidate drug selection and development programmes to bring more effective drugs to market more quickly.

What Else are Gifford Bioscience Doing?

Gifford Bioscience are a fast-growing scientific research business, but they adhere tightly to their core expertise in testing how and where a potential new medical drug binds to its intended target in the body.

The assay services currently offered by Gifford Bioscience include:

  • Receptor Occupancy – Assays that measure the degree to which a test substance occupies its target receptor in tissues or animals.

  • Radioligand Binding – These assays are considered the gold standard for measuring the affinity of ligand binding to a target receptor, due to their high levels of robustness and sensitivity.

  • Receptor Autoradiography – Used for identifying receptor binding sites and the distribution of radiolabelled drugs in tissue or organ sections.

  • Cellular Uptake and Release – Used to measure a compound’s transport into cells or efflux from cells. They can also determine a compound’s potency and efficacy.

  • Custom Radiolabelling – Small molecules, peptides and proteins can be custom radiolabelled by Gifford Bioscience, for use with their assay services.

Share article on social media or email: